Form EFFECT BridgeBio Oncology Thera

September 9, 2026 6:05 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 8, 2026
Accession Number: 0001193125-26-378366
Submission Type: POS AM
CIK: 0001869105
Company Name: BridgeBio Oncology Therapeutics, Inc.
File Number: 333-289940


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings